NASDAQ · NRIX
Nurix Therapeutics, Inc.
Healthcare · Biotechnology
$15.30
Up+$0.46 (+3.10%)
Updated Nov 8, 2026, 3:10 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.47B
- P/E ratio
- -6.56
- Dividend yield
- 0.00%
- 52-week range
- $11.67 – $28.23
- Volume
- 2.98M
- Avg. volume
- 1.68M
Price performance · NRIX
NRIX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
NRIX closed at $15.30 after 20 trading sessions, down 30.96% for the selected period.
- Last close
- $15.30
- Period change
- -30.96%
- Period low
- $14.84
- Period high
- $27.26
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $15.10 | $15.52 | $14.791 | $15.30 | 2.98M |
| Nov 5, 2026 | $16.01 | $16.5939 | $14.80 | $14.84 | 7.09M |
| Nov 4, 2026 | $17.16 | $17.28 | $14.78 | $15.95 | 19.56M |
| Nov 3, 2026 | $25.72 | $26.55 | $25.6325 | $25.82 | 4.39M |
| Nov 2, 2026 | $26.75 | $26.9569 | $25.532 | $25.70 | 2.35M |
| Oct 30, 2026 | $26.90 | $26.915 | $25.97 | $26.80 | 2.31M |
| Oct 29, 2026 | $27.46 | $27.99 | $26.685 | $27.12 | 2.38M |
| Oct 28, 2026 | $26.26 | $27.28 | $25.45 | $27.26 | 1.96M |
| Oct 27, 2026 | $25.52 | $27.05 | $25.13 | $26.70 | 2.56M |
| Oct 26, 2026 | $25.35 | $25.82 | $25.03 | $25.55 | 2.34M |
| Oct 23, 2026 | $25.22 | $25.49 | $24.775 | $25.34 | 1.91M |
| Oct 22, 2026 | $25.86 | $26.225 | $25.1801 | $25.51 | 1.93M |
| Oct 21, 2026 | $26.00 | $26.31 | $25.80 | $26.02 | 2.93M |
| Oct 20, 2026 | $24.92 | $26.34 | $24.71 | $26.10 | 3.98M |
| Oct 19, 2026 | $24.57 | $25.29 | $24.3837 | $24.93 | 3.06M |
| Oct 16, 2026 | $24.89 | $25.355 | $24.265 | $24.42 | 4.32M |
| Oct 15, 2026 | $23.67 | $25.135 | $23.61 | $24.95 | 3.75M |
| Oct 14, 2026 | $22.012 | $24.01 | $21.40 | $23.67 | 3.82M |
| Oct 13, 2026 | $22.16 | $23.24 | $21.75 | $22.13 | 4.68M |
| Oct 12, 2026 | $22.27 | $22.575 | $22.025 | $22.16 | 2.85M |
Latest NRIX news
The latest Smart Investors Daily articles mentioning NRIX.
Stock researchResearch & News · News
Company
Market Activity
Research & News

